Search Medical Condition
Please enter condition
Please choose location from dropdown

Bloomfield Hills, Michigan Clinical Trials

A listing of Bloomfield Hills, Michigan clinical trials actively recruiting patient volunteers.

RESULTS

Found (403) clinical trials

Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies

The purpose of this world-wide prospective parallel-cohort study in patients with relapsing forms of MS, either newly treated with fingolimod or receiving another disease-modifying therapy, is to further explore the incidence of selected safety- related outcomes and to further monitor the overall safety profile of fingolimod under conditions of routine ...

Phase N/A

0.0 miles

Learn More »

Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis

Primary Hypothesis: Restrictive (vs liberal) fluid treatment strategy during the first 24 hours of resuscitation for sepsis-induced hypotension will reduce 90-day in-hospital mortality. We will emphasize early screening and protocol initiation, and enroll a maximum of 2320 patients with suspected sepsis-induced hypotension. All patients will receive at least 1 liter ...

Phase

1.51 miles

Learn More »

Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms

Ten year safety study examining rates of rare adverse events, child bearing issues, effects of mammography, MRI compliance and results, and long-term benefit of silicone-filled breast implants.

Phase N/A

2.09 miles

Learn More »

Effects of AZD1775 on the PK Substrates for CYP3A CYP2C19 CYP1A2 and on QT Interval in Patients With Advanced Cancer

This is a Phase I, 2-part study (Part A and Part B) in patients with advanced solid tumours. Part A: Part A of this study is an open-label, non-randomised, 2-period design. The treatment starts with the administration of a cocktail of 3 medications: caffeine, omeprazole and midazolam (Day -8), followed ...

Phase

2.09 miles

Learn More »

AZD1775 Continued Access Study to Assess Safety and Tolerability for Patients Enrolled in AZD1775 Clinical Pharmacology Studies

This is an open-label, non-randomised study designed to provide continued access to AZD1775 for eligible patients with advanced solid tumours who have previously completed an AZD1775 clinical pharmacology study and to investigate the safety of a once daily monotherapy regimen of AZD1775 in patients with advanced solid tumours. All patients ...

Phase

2.09 miles

Learn More »

You may be able to be in a clinical research study if you suffer from the pain experienced after having shingles, also known as post-herpetic neuralgia (PHN) The purpose of this study is to see if an investigational pain drug works safely to reduce PHN pain. Patient Inclusion Criteria: Are ...

Phase

2.09 miles

Learn More »

This study is to investigate a therapy for women having fairly regular periods that have not yet gone through menopause. The study requires six visits to QUEST and compensates volunteers up to $ 550 for their time and travel. Patient Inclusion Criteria: At least 18 years old Patient Exclusion Criteria: ...

Phase

2.09 miles

Learn More »

This long term study evaluates the safety and efficacy of an investigational treatment compared to allopurinol in people who have both gout and cardiovascular disease. Participants will receive compensation for their time and travel; $50 for each completed office visit and $15 for each completed telephone call throughout the study. ...

Phase

2.09 miles

Learn More »

QUEST Research Institute is conducting a clinical research study of an investigational treatment for RA. Clinical trials play a key role in evaluating the safety and effectiveness of investigational drugs. The study requires 5 visits with the medical research staff at the clinic in Bingham Farms, MI All qualified participants ...

Phase

2.09 miles

Learn More »

Have you had a major cardiovascular event within the past 5 years? Study will evaluate a new injectable drug to help lower cholesterol in subjects with cardiovascular risk factors.

Phase

2.09 miles

Learn More »